StockCalc Blog

Harsco (HSC:NYS) Fundamental Valuation Report

By admin Posted on May 3, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Harsco(HSC:NYS) Industrials:Specialty Industrial Machinery This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$17.93 (USD) 04/30/2021 Weighted Valuation$21.00 (USD) Overall RatingUndervalued by 17.1% Valuation Models Comparables: $27.30 (USD) Multiples: $23.21 …

Harsco (HSC:NYS) Fundamental Valuation Report Read more »

Host Hotels & Resorts (HST:NAS) Fundamental Valuation Report

By admin Posted on May 3, 2021 Posted in Fundamental Valuation Report

Finance trade manager analysing stock market indicators for best investment strategy, financial data and charts with business buildings in background

Fundamental Valuation Report Host Hotels & Resorts(HST:NAS) Real Estate:REIT – Hotel & Motel This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$18.16 (USD) 04/30/2021 Weighted Valuation$18.08 (USD) Overall RatingFairly …

Host Hotels & Resorts (HST:NAS) Fundamental Valuation Report Read more »

Intercept Pharmaceuticals (ICPT:NAS) Fundamental Valuation Report

By admin Posted on May 3, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Intercept Pharmaceuticals(ICPT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$19.78 (USD) 04/30/2021 Weighted Valuation$10.32 (USD) Overall RatingOvervalued by 47.8% Valuation Models Comparables: $10.32 (USD) Valuation Methods …

Intercept Pharmaceuticals (ICPT:NAS) Fundamental Valuation Report Read more »

IDEX (IEX:NYS) Fundamental Valuation Report

By admin Posted on May 3, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report IDEX(IEX:NYS) Industrials:Specialty Industrial Machinery This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$224.20 (USD) 04/30/2021 Weighted Valuation$213.65 (USD) Overall RatingFairly valued to slightly Overvalued by 4.7% Valuation Models …

IDEX (IEX:NYS) Fundamental Valuation Report Read more »

iHeartMedia (IHRT:NAS) Fundamental Valuation Report

By admin Posted on May 3, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report iHeartMedia(IHRT:NAS) Communication Services:Broadcasting This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$19.14 (USD) 04/30/2021 Weighted Valuation$25.00 (USD) Overall RatingUndervalued by 30.6% Valuation Models Comparables: $37.71 (USD) Valuation Methods …

iHeartMedia (IHRT:NAS) Fundamental Valuation Report Read more »

PVH (PVH:NYS) Fundamental Valuation Report

By admin Posted on April 30, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report PVH(PVH:NYS) Consumer Cyclical:Apparel Manufacturing This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$114.05 (USD) 04/29/2021 Weighted Valuation$113.86 (USD) Overall RatingFairly valued to slightly Overvalued by 0.2% Valuation Models …

PVH (PVH:NYS) Fundamental Valuation Report Read more »

Abercrombie & Fitch (ANF:NYS) Fundamental Valuation Report

By admin Posted on April 30, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Abercrombie & Fitch(ANF:NYS) Consumer Cyclical:Apparel Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$37.70 (USD) 04/29/2021 Weighted Valuation$40.50 (USD) Overall RatingUndervalued by 7.4% Valuation Models Discounted …

Abercrombie & Fitch (ANF:NYS) Fundamental Valuation Report Read more »

Guardant Health (GH:NAS) Fundamental Valuation Report

By admin Posted on April 30, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Guardant Health(GH:NAS) Healthcare:Diagnostics & Research This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$160.70 (USD) 04/29/2021 Weighted Valuation$138.78 (USD) Overall RatingOvervalued by 13.6% Valuation Models Comparables: $153.46 (USD) …

Guardant Health (GH:NAS) Fundamental Valuation Report Read more »

Gilead Sciences (GILD:NAS) Fundamental Valuation Report

By admin Posted on April 30, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Gilead Sciences(GILD:NAS) Healthcare:Drug Manufacturers – General This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$63.84 (USD) 04/29/2021 Weighted Valuation$68.09 (USD) Overall RatingUndervalued by 6.7% Valuation Models Comparables: $67.83 …

Gilead Sciences (GILD:NAS) Fundamental Valuation Report Read more »

Globe Life (GL:NYS) Fundamental Valuation Report

By admin Posted on April 30, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Globe Life(GL:NYS) Financial Services:Insurance – Life This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$103.43 (USD) 04/29/2021 Weighted Valuation$107.50 (USD) Overall RatingFairly valued to slightly Undervalued by 3.9% …

Globe Life (GL:NYS) Fundamental Valuation Report Read more »

Notice to User:

Risk Disclosure:
Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results.

Hypothetical Performance Disclosure:
Hypothetical performance results have many inherent limitations, some of which are described below. no representation is being made that any account will or is likely to achieve profits or losses similar to thoseshown; in fact, there are frequently sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular trading program. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. for example, the ability to withstand losses or to adhere to a particular trading program in spite of trading losses are material points which can also adversely affect actual trading results. There are numerous other factors related to the markets in general or to the implementation of any specific trading program which cannot be fully accounted forin the preparation of hypothetical performance results and all which can adversely affect trading results.

Live Trades Disclosure:
This presentation is for educational purposes only and the opinions expressed are those of the presenter only. All trades presented should be considered hypothetical and should not be expected to be replicated in a live trading account.